INNOVACAP IPO

Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. The business includes (i) a contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business and (iii) an international branded generics business.

The foundation of the company is in-house R&D, they have a dedicated R&D laboratory and pilot equipment located at their manufacturing facility in Baddi, Himachal Pradesh, which is recognized by Department of Scientific and Industrial Research (DSIR) Government of India.

ABOUT THE INDUSTRY

The global pharmaceuticals market clocked a 5% CAGR between calendar years 2017 and 2022. The industry is expected to sustain this growth over the next five years to reach approximately US$1,750 to 1,800 billion in 2027, clocking a 4.5% to 5% CAGR. Indian domestic formulations market (consumption) grew at a healthy rate at a CAGR of 9% from fiscal 2018 to fiscal 2023. The segment is expected to grow at a CAGR of 9-10% CAGR over the next five years to reach approximately Rs. 2.8-3.0 trillion in fiscal 2028, aided by strong demand because of rising incidence of chronic diseases, increased awareness and access to quality healthcare.